# Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients

> **NCT04390984** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 22 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Apatinib Mesylate, Gefitinib

## Key facts

- **NCT ID:** NCT04390984
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-26
- **Primary completion:** 2021-02
- **Final completion:** 2021-03
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04390984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04390984, "Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04390984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*